oncology

Why do so many kids die so soon following a cancer diagnosis?While improvements have been made to childhood cancer mortality rates, a recent research study aims to identify how many children die before being able to start treatment, and what interventions can be put in place to improve their chances.
The Future of Oncology Treatment Is Value AssessmentHow value assessment tools enhance decision-making in oncology.
Pharmaceutical pipeline: Top 4 conditions to watch
Pharmaceutical pipeline: Top 4 conditions to watchAlthough drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.
Multiple myeloma treatment advances: What health execs should knowIt has been an exciting time at the Myeloma Institute at the University of Arkansas for Medical Sciences, on all fronts, namely, embarking on research that could play an important role in the development of preventative and curative strategies for multiple myeloma in the future.
Reimagineering chemotherapyFun isn’t what you’d typically expect in a chemotherapy infusion room. Yet, that’s precisely the environment an adolescent and young adult oncologist and a former Disney Imagineer created with the Infusionarium concept.
Top 5 specialty drug management issuesThe 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.
Robust multiple myeloma treatment program holds promiseThe Medical College of Wisconsin’s multiple myeloma program is robust and growing.
Innovative strategies help fight multiple myeloma: What every exec should knowAs new scientific advancements occur at the genetic and protein levels, more strategies have been developed to identify and combat multiple myeloma.
Regulatory changes for community oncology: What health execs should knowOne thing that is unlikely to change under the new Administration is the goal of reducing the cost of healthcare through various alternative payment initiatives. Here’s how that will affect oncology.
Game changing idea: Specialty intensive medical homeBlue Cross Blue Shield of Illinois partners with gastroenterology group to focus on Crohn’s disease patients.